4JaniV,Janossy G,Iqbal A,et al Affordable CD4 T cell counts by flow cytometry II.The use of fixed whole blood in resource porr settings[J].J Im munol Methods,2001,257(1-2):145-154.
4Lo-Coco F, Foa R. Diagnostic and prognostic advances in the immunophenotypic and genetic characterization of acute leukaemia[J]. Eur J Haematol, 1995, 55(1): 1-9.
5Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Europoan Group for the Immunological Characterization of Lcukemias (EGIL) [ J ]. Leukemia, 1995, 9(10): 1783-6.
6Jennings CD, Foon KA. Recent advances in flow cytometry:, application to the diagnosis of hematologic malignancy[J]. Blood, 1997,90(8): 2863-92.
7Khalidi HS, Medeiros LJ, Chang KL, et al. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and katyotypic abnormalities[J].Am J Clin Pathol, 1998, 109(2): 211-20.
8Casasnovas RO, Slimane FK, Garand R, et al. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome[J]. Leukemia, 2003, 17(3): 515-27.
9Baer MR, Stewart CC, Lawrence D, et aL Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8;21)(q22;q22)[J]. Blood, 1997, 90(4): 1643-8.
10Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia[J]. Leuk Res, 1999, 23(7): 615-24.
